Healthcare groups are condemning the FDA’s decision to issue narrow approvals for COVID-19 vaccines, saying the move will limit access for millions of Americans and raise the risk of severe outcomes ahead of respiratory virus season. On Aug. 27, the FDA approved updated vaccines targeting newer strains of the virus from Pfizer, Moderna and Novavax. […]
